APEI vs EPC

APEI's deterministic health scores signal significant concerns: a Piotroski F-Score of 2/9 indicates weak financial health, while the absence of an Altman Z-Score raises red flags for potential distress risk. Despite strong earnings surprises and robust historical EPS growth, the stock trades at a rich forward P/E of 15.44 and a current P/E of 44.02, well above sector averages and its intrinsic value of $24.30. The company shows deteriorating revenue growth (-3.5% YoY) and negative insider sentiment with two recent sell transactions. Although profitability metrics remain positive, the combination of weak financial strength, overvaluation, and declining top-line performance suggests a high-risk profile.

EPC presents a stark contradiction between operational health and valuation. While the Piotroski F-Score of 7/9 indicates strong short-term financial health and operational stability, the company is fundamentally overvalued relative to its Graham Number ($8.87) and Intrinsic Value ($0.77). A catastrophic YoY EPS decline of -328.6% and an unsustainable dividend payout ratio of 545.45% signal severe earnings distress, despite a bullish analyst consensus based on a low Forward P/E.